My bet is GILD is going to acquire other oncology assets to complement recent Calistoga and Arresto Biosciences acquisition. IDIX was up over 10% on 5x it's average trade on no apparent news. Some may be speculating GILD is shopping for a HCV nuke aka IDX-184.
Market Data 
Markets
AI
